DISCLAIMER
The 'Next Edge Bio-Tech Plus Fund' or 'Fund' means the 'Next Edge Bio-Tech Plus Fund'. Capitalized terms not defined in this presentation are defined as set forth in the prospectus of the Fund (the 'Prospectus'). This communication is not, and under no circumstances is to be construed as, an invitation to make an investment in the Fund nor does it constitute a public offering to sell the Fund or any other products described herein. Applications for the Fund will only be considered on the terms of the Prospectus. Each purchaser of the units (the 'Units') may have statutory or contractual rights of action under certain circumstances as disclosed in the Prospectus. Please review the provisions of the applicable securities legislation for particulars of these rights.. Terms defined herein shall have the same meaning as in the Prospectus. Potential investors should note that alternative investments can involve significant risks and the value of an investment may go down as well as up. There is no guarantee of trading performance and past or projected performance is not indicative of future results. Investors should review the Prospectus in its entirety for a complete description of the Fund, its risks, and consult their registered dealers before making an investment. The information contained in this material is subject to change without notice and Next Edge Capital Corp. will not be held liable for any inaccuracies or misprints. The Fund has not been and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States. The Fund may not be offered or sold in the United States or to US persons. Any descriptions or information involving investment process or strategies is provided for illustration purposes only, may not be fully indicative of any present or future investments, may be changed at the discretion of the Investment Manager and are not intended to reflect performance. The following does not purport to be a complete summary of all of the risks associated with an investment in the Fund. Please see the Fund's Prospectus for a complete listing and description of the risks associated with an investment in the Fund. The Fund is generally exposed to the following risks: Biotechnology Risk; Derivatives Risk; Equity Securities Risk; FACTA Risk; Foreign Currency Risk; Foreign Securities Risk; Legislation and Litigation Risk; Liquidity Risk; Multiple Class Risk; Options Risk; Sector Risk; Stock Market Risk; Substantial Securityholder Risk.